These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 31119850
1. New Organometallic Tetraphenylethylene⋅Iridium(III) Complexes with Antineoplastic Activity. Liu X, He X, Zhang X, Wang Y, Liu J, Hao X, Zhang Y, Yuan XA, Tian L, Liu Z. Chembiochem; 2019 Nov 04; 20(21):2767-2776. PubMed ID: 31119850 [Abstract] [Full Text] [Related]
2. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y, Guo L, Tian Z, Gong Y, Zheng H, Zhang S, Xu Z, Ge X, Liu Z. Inorg Chem; 2018 Sep 04; 57(17):11087-11098. PubMed ID: 30133276 [Abstract] [Full Text] [Related]
3. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J, Tian M, Tian Z, Zhang S, Yan C, Shao C, Liu Z. Inorg Chem; 2018 Feb 19; 57(4):1705-1716. PubMed ID: 29400963 [Abstract] [Full Text] [Related]
4. Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application. Han Y, Liu X, Tian Z, Ge X, Li J, Gao M, Li Y, Liu Y, Liu Z. Chem Asian J; 2018 Dec 04; 13(23):3697-3705. PubMed ID: 30276978 [Abstract] [Full Text] [Related]
5. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity. Li J, Guo L, Tian Z, Tian M, Zhang S, Xu K, Qian Y, Liu Z. Dalton Trans; 2017 Nov 14; 46(44):15520-15534. PubMed ID: 29090698 [Abstract] [Full Text] [Related]
14. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands. Ludwig G, Ranđelović I, Maksimović-Ivanić D, Mijatović S, Bulatović MZ, Miljković D, Korb M, Lang H, Steinborn D, Kaluđerović GN. ChemMedChem; 2014 Jul 14; 9(7):1586-93. PubMed ID: 24470190 [Abstract] [Full Text] [Related]
15. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria. Zhang H, Tian L, Xiao R, Zhou Y, Zhang Y, Hao J, Liu Y, Wang J. Bioorg Chem; 2021 Oct 14; 115():105290. PubMed ID: 34426145 [Abstract] [Full Text] [Related]
16. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study. Yellol J, Pérez SA, Buceta A, Yellol G, Donaire A, Szumlas P, Bednarski PJ, Makhloufi G, Janiak C, Espinosa A, Ruiz J. J Med Chem; 2015 Sep 24; 58(18):7310-27. PubMed ID: 26313136 [Abstract] [Full Text] [Related]
17. Triphenylamine-appended cyclometallated iridium(III) complexes: Preparation, photophysical properties and application in biology/luminescence imaging. Liu X, Hao H, Ge X, He X, Liu Y, Wang Y, Wang H, Shao M, Jing Z, Tian L, Liu Z. J Inorg Biochem; 2019 Oct 24; 199():110757. PubMed ID: 31445461 [Abstract] [Full Text] [Related]
18. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes. Zhang H, Guo L, Tian Z, Tian M, Zhang S, Xu Z, Gong P, Zheng X, Zhao J, Liu Z. Chem Commun (Camb); 2018 Apr 26; 54(35):4421-4424. PubMed ID: 29648559 [Abstract] [Full Text] [Related]
19. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties. Li Y, Liu B, Xu CX, He L, Wan YC, Ji LN, Mao ZW. J Biol Inorg Chem; 2020 Jun 26; 25(4):597-607. PubMed ID: 32232583 [Abstract] [Full Text] [Related]
20. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis. Chen BB, Pan NL, Liao JX, Huang MY, Jiang DC, Wang JJ, Qiu HJ, Chen JX, Li L, Sun J. J Inorg Biochem; 2021 Jun 26; 219():111450. PubMed ID: 33826973 [Abstract] [Full Text] [Related] Page: [Next] [New Search]